CAW
Cornerstone Advisors (Washington) Portfolio holdings
AUM
$936M
1-Year Return
8.77%
This Quarter Return
+20.42%
1 Year Return
+8.77%
3 Year Return
+24.32%
5 Year Return
+57.22%
10 Year Return
–
AUM
$914M
AUM Growth
+$190M
(+26%)
Cap. Flow
+$43.5M
Cap. Flow
% of AUM
4.76%
Top 10 Holdings %
Top 10 Hldgs %
91.69%
Holding
833
New
74
Increased
361
Reduced
226
Closed
121
Top Buys
| 1 |
Vanguard Large-Cap ETF
VV
|
$27.5M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
$24.3M |
| 3 |
iShares MSCI ACWI ETF
ACWI
|
$12.8M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
$9.26M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
$8.53M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
$27.7M |
| 2 |
Vanguard Mid-Cap ETF
VO
|
$7.79M |
| 3 |
Vanguard Small-Cap ETF
VB
|
$7.25M |
| 4 |
iShares Russell 2000 Value ETF
IWN
|
$1.17M |
| 5 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
$1.02M |
Sector Composition
| 1 | Technology | 2.74% |
| 2 | Consumer Staples | 1.05% |
| 3 | Healthcare | 1% |
| 4 | Consumer Discretionary | 0.98% |
| 5 | Industrials | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Coca-Cola
KO
$294B
| $736K | 0.08% |
16,469
+110
| +0.7% | +$4.92K |
|
27
Gilead Sciences
GILD
$140B
| $730K | 0.08% |
9,482
+442
| +5% | +$34K |
|
28
Yum! Brands
YUM
$39.9B
| $715K | 0.08% |
8,231
+322
| +4% | +$28K |
|
29
Bristol-Myers Squibb
BMY
$95B
| $654K | 0.07% |
11,122
+1,157
| +12% | +$68K |
|
30
McDonald's
MCD
$226B
| $652K | 0.07% |
3,537
+66
| +2% | +$12.2K |
|
31
Vanguard Growth ETF
VUG
$187B
| $619K | 0.07% |
3,062
-987
| -24% | -$200K |
|
|
JWN
32
DELISTED
Nordstrom
JWN
| $585K | 0.06% |
37,778
-720
| -2% | -$11.1K |
|
33
Nike
NKE
$111B
| $574K | 0.06% |
5,856
+572
| +11% | +$56.1K |
|
34
DocuSign
DOCU
$15.4B
| $569K | 0.06% |
3,303
+164
| +5% | +$28.3K |
|
35
Danaher
DHR
$143B
| $561K | 0.06% |
3,578
+474
| +15% | +$74.3K |
|
36
iShares Russell 2000 ETF
IWM
$67.4B
| $552K | 0.06% |
3,857
-168
| -4% | -$24K |
|
37
lululemon athletica
LULU
$24.7B
| $544K | 0.06% |
1,742
+424
| +32% | +$132K |
|
38
Union Pacific
UNP
$132B
| $531K | 0.06% |
3,142
+453
| +17% | +$76.6K |
|
39
Chevron
CVX
$318B
| $522K | 0.06% |
5,848
+1,517
| +35% | +$135K |
|
40
Citigroup
C
$179B
| $513K | 0.06% |
10,048
+975
| +11% | +$49.8K |
|
41
Kimberly-Clark
KMB
$42.9B
| $509K | 0.06% |
3,603
+247
| +7% | +$34.9K |
|
42
Lowe's Companies
LOW
$148B
| $499K | 0.05% |
3,692
+643
| +21% | +$86.9K |
|
43
Walmart
WMT
$805B
| $483K | 0.05% |
12,087
+2,196
| +22% | +$87.8K |
|
44
Novo Nordisk
NVO
$249B
| $475K | 0.05% |
14,502
+1,768
| +14% | +$57.9K |
|
45
Mondelez International
MDLZ
$78.8B
| $464K | 0.05% |
9,078
-67
| -0.7% | -$3.43K |
|
46
ResMed
RMD
$40.1B
| $455K | 0.05% |
2,371
+70
| +3% | +$13.4K |
|
47
Morgan Stanley
MS
$240B
| $451K | 0.05% |
9,332
+687
| +8% | +$33.2K |
|
48
Pfizer
PFE
$140B
| $443K | 0.05% |
14,285
+3,660
| +34% | +$114K |
|
49
Eli Lilly
LLY
$666B
| $437K | 0.05% |
2,664
+471
| +21% | +$77.3K |
|
50
Ecolab
ECL
$78B
| $418K | 0.05% |
2,099
-39
| -2% | -$7.77K |
|